Human ANXA2/LIP2/LPC2 ORF/cDNA clone-Lentivirus plasmid (BC009564)

Cat. No.: pGMLP004063
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human ANXA2/LIP2/LPC2 Lentiviral expression plasmid for ANXA2 lentivirus packaging, ANXA2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to Annexin A2/ANXA2/ANXA2/LIP2 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $585.6
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP004063
Gene Name ANXA2
Accession Number BC009564
Gene ID 302
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 1020 bp
Gene Alias LIP2,LPC2,P36,PAP-IV
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGTCTACTGTTCACGAAATCCTGTGCAAGCTCAGCTTGGAGGGTGATCACTCTACACCCCCAAGTGCATATGGGTCTGTCAAAGCCTATACTAACTTTGATGCTGAGCGGGATGCTTTGAACATTGAAACAGCCATCAAGACCAAAGGTGTGGATGAGGTCACCATTGTCAACATTTTGACCAACCGCAGCAATGCACAGAGACAGGATATTGCCTTCGCCTACCAGAGAAGGACCAAAAAGGAACTTGCATCAGCACTGAAGTCAGCCTTATCTGGCCACCTGGAGACGTTGATTTTGGGCCTATTGAAGACACCTGCTCAGTATGACGCTTCTGAGCTAAAAGCTTCCATGAAGGGGCTGGGAACCGACGAGGACTCTCTCATTGAGATCATCTGCTCCAGAACCAACCAGGAGCTGCAGGAAATTAACAGAGTCTACAAGGAAATGTACAAGACTGATCTGGAGAAGGACATTATTTCGGACACATCTGGTGACTTCCGCAAGCTGATGGTTGCCCTGGCAAAGGGTAGAAGAGCAGAGGATGGCTCTGTCATTGATTATGAACTGATTGACCAAGATGCTCGGGATCTCTATGACGCTGGAGTGAAGAGGAAAGGAACTGATGTTCCCAAGTGGATCAGCATCATGACCGAGCGGAGCGTGCCCCACCTCCAGAAAGTATTTGATAGGTACAAGAGTTACAGCCCTTATGACATGTTGGAAAGCATCAGGAAAGAGGTTAAAGGAGACCTGGAAAATGCTTTCCTGAACCTGGTTCAGTGCATTCAGAACAAGCCCCTGTATTTTGCTGATCGGCTGTATGACTCCATGAAGGGCAAGGGGACGCGAGATAAGGTCCTGATCAGAATCATGGTCTCCCGCAGTGAAGTGGACATGTTGAAAATTAGGTCTGAATTCAAGAGAAAGTACGGCAAGTCCCTGTACTATTATATCCAGCAAGACACTAAGGGCGACTACCAGAAAGCGCTGCTGTACCTGTGTGGTGGAGATGACTGA
ORF Protein Sequence MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETLILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-T04386-Ab Anti-ANXA2/ ANX2/ ANX2L4 monoclonal antibody
    Target Antigen GM-Tg-g-T04386-Ag ANXA2 VLP (virus-like particle)
    ORF Viral Vector pGMLP004063 Human ANXA2 Lentivirus plasmid
    ORF Viral Vector pGMLP004100 Human ANXA2 Lentivirus plasmid
    ORF Viral Vector pGMLV000652 Human ANXA2 Lentivirus plasmid
    ORF Viral Vector pGMAP000385 Human ANXA2 Adenovirus plasmid
    ORF Viral Vector pGMPC000610 Human ANXA2 Mammalian (Non-Viral Vector) plasmid
    ORF Viral Vector vGMLP004063 Human ANXA2 Lentivirus particle
    ORF Viral Vector vGMLP004100 Human ANXA2 Lentivirus particle
    ORF Viral Vector vGMLV000652 Human ANXA2 Lentivirus particle
    ORF Viral Vector vGMAP000385 Human ANXA2 Adenovirus particle


    Target information

    Target ID GM-T04386
    Target Name Annexin A2/ANXA2
    Gene Group Identifier
    （Target Gene ID in Homo species)         		302
    Gene ID 100054320 (Equus caballus), 101093022 (Felis catus), 12306 (Mus musculus), 282689 (Bos taurus)
    302 (Homo sapiens), 403435 (Canis lupus familiaris), 56611 (Rattus norvegicus), 706240 (Macaca mulatta)
    Gene Symbols & Synonyms ANXA2,Anxa2,p36,Cal1h,PAP-IV,P36,ANX2,LIP2,LPC2,CAL1H,LPC2D,ANX2L4,HEL-S-270,Annexin-2
    Target Alternative Names ANX2,ANX2L4,ANXA2,Annexin A2,Annexin II,Annexin-2,Anxa2,CAL1H,Cal1h,Calpactin I heavy chain,Calpactin-1 heavy chain,Chromobindin-8,HEL-S-270,LIP2,LPC2,LPC2D,Lipocortin II,P36,PAP-IV,Placental anticoagulant protein IV (PAP-IV),Protein I,p36
    Uniprot Accession P04272,P07355,P07356,Q07936,Q6TEQ7
    Additional SwissProt Accessions: P07356,P04272,P07355,Q6TEQ7,Q07936
    Uniprot Entry Name
    Protein Sub-location Transmembrane Protein
    Category Therapeutics Target
    Disease cancer, Ovary Cancer
    Disease from KEGG
    Gene Ensembl ENSECAG00000012670, ENSMUSG00000032231, ENSBTAG00000009615, ENSG00000182718, ENSCAFG00845017171, ENSMMUG00000012000
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.